3V2-10867-48115

5 vaccinations 9 coded responses 34 check-ins 7 free-text entries 6 call cases

Sex: Female
Age at first dose: 56-60
ZIP prefix: 488 / MI
Registered: 2021-03-15

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-10
Dose 1 — Pfizer-BioNTech
2021-03-15
Registered in v-safe
2021-03-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-17
Health check-in — day 7, dose 1
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-24
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-31
Dose 2 — Pfizer-BioNTech
2021-03-31
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2021-04-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness

Adult check-in
2021-04-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling, Itching · None

Adult check-in
2021-04-06
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness

Free text: Swollen gland in arm pit same side as vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-07
Survey response — day 7, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling, Itching

Free text: Still have swollen lymph node in armpit, same arm as vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-14
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-21
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-28
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-05
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-12
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-30
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-09-03
Dose 3 — Pfizer-BioNTech
2021-10-02
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-04-02
Survey response — 12 months, dose 2
MedDRA: Office visit, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: Possibly developing psoriasis or psoriatic arthritis. · Healthcare visit (other): Scheduled visit to rheumatologist

MedDRA releases: 2024-11 · check-in free text available
2022-04-02
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2022-04-05
Call 1 — Left Voicemail
2022-04-22
Dose 4 — Pfizer-BioNTech
2022-04-24
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain, Redness · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-04-25
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · None

Adult check-in
2022-04-26
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-04-27
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-04-28
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-05-01
Survey response — day 7, dose 4
MedDRA: Nasal congestion, Sneezing — Feeling: Fair

Free text: Stuffy nose, sneezing

MedDRA releases: 2024-11 · check-in free text available
2022-05-10
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-05-13
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-05-20
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-05-28
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-06-03
Survey response — day 42, dose 4
MedDRA: Office visit, Psoriasis — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: I'm apparently developing psoriasis. · Healthcare visit (other): Doctors visit, not urgent care

MedDRA releases: 2024-11 · check-in free text available
2022-06-03
Report sent to call center — day 42, dose 4
Get care from a doctor or other healthcare professional

1 call case(s)
2022-06-06
Call 2 — Left Voicemail
2022-06-06
Call 1 — Left Voicemail
2022-07-22
Survey response — 3 months, dose 4
MedDRA: Office visit, Pre-existing disease, Psoriasis, Rheumatoid arthritis — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: Developing psoriasis and increased in RA symptoms. New medication has been added to current regimen. · Healthcare visit (other): Physician's office

MedDRA releases: 2024-11 · check-in free text available
2022-07-22
Report sent to call center — 3 months, dose 4
Get care from a doctor or other healthcare professional

1 call case(s)
2022-07-25
Call 3 — Left Voicemail
2022-07-25
Call 2 — Left Voicemail
2022-07-25
Call 1 — Left Voicemail
2022-10-21
Survey response — 6 months, dose 4
MedDRA: Arthralgia, COVID-19, Fatigue, Myalgia, Psoriasis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Worsening psoriasis and joint/muscle pain, fatigue. COVID on 9/12

MedDRA releases: 2024-11 · check-in free text available
2022-10-21
Report sent to call center — 6 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-10-24
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-24
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-24
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-24
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-01-18
Dose 5 — Pfizer-BioNTech
2023-04-24
Survey response — 12 months, dose 4
MedDRA: Office visit, Pre-existing disease, Rheumatoid arthritis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

MedDRA releases: 2024-11
2023-04-24
Survey response — 3 months, dose 5
MedDRA: Office visit, Pre-existing disease, Rheumatoid arthritis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

MedDRA releases: 2024-11
2023-04-24
Report sent to call center — 12 months, dose 4
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2023-04-24
Report sent to call center — 3 months, dose 5
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2023-04-25
Call 1 — Left Voicemail
2023-04-25
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-10	Pfizer-BioNTech
2	2021-03-31	Pfizer-BioNTech
3	2021-09-03	Pfizer-BioNTech	No
4	2022-04-22	Pfizer-BioNTech	No
5	2023-01-18	Pfizer-BioNTech	No

Call center

6 call center cases

4 successful · 2 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-06

Systemic reaction (other): Swollen gland in arm pit same side as vaccine.

Release 7 — day 7, dose 2

2021-04-07

Systemic reaction (other): Still have swollen lymph node in armpit, same arm as vaccine.

Release 11 — 12 months, dose 2

2022-04-02

Symptoms: Possibly developing psoriasis or psoriatic arthritis.

Healthcare visit (other): Scheduled visit to rheumatologist

Release 11 — day 7, dose 4

2022-05-01

Systemic reaction (other): Stuffy nose, sneezing

Release 11 — day 42, dose 4

2022-06-03

Symptoms: I'm apparently developing psoriasis.

Healthcare visit (other): Doctors visit, not urgent care

Release 12 — 3 months, dose 4

2022-07-22

Symptoms: Developing psoriasis and increased in RA symptoms. New medication has been added to current regimen.

Healthcare visit (other): Physician's office

Release 12 — 6 months, dose 4

2022-10-21

Symptoms: Worsening psoriasis and joint/muscle pain, fatigue. COVID on 9/12

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Arthralgia	·	·	✓
SD	COVID-19	·	·	✓
SD	Fatigue	·	·	✓
SD	Myalgia	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Psoriasis	·	·	✓
SD	Rheumatoid arthritis	·	·	✓
SD	Unevaluable event	·	·	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Nasal congestion	·	·	✓
SRO	Sneezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release